Consumer Defensive
Live Price
Offline$5.02
+0.80% today
1Y Change
-33.38%
Window
Jun 25, 2025 โ Jun 15, 2026
Coverage: 244 bars ยท Jun 25, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Nu Skin Enterprises, Inc. (NUS) is a Consumer Defensive stock with a market cap of $350.00M and listed on NYSE. The stock last traded around $5.02 and down 33.4% across the available one-year price window (Jun 25, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of -14.3%, EPS growth of +210.2%, a dividend yield of 3.3%. What stands out right now is revenue -14.3%, EPS +210.2%, free cash flow -34.4% with operating margin 4.4% and ROIC 4.6%. The dividend matters to the case here, with a current yield around 3.3%. Valuation is more restrained than many high-expectation growth names at P/E 2.2 and price/sales 0.2. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines NUS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-14.3% vs +1.7% peer median
Operating Margin
Below sector median
+4.4% vs +6.6% peer median
P/E
Below sector median
2.2 vs 14.0 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 14, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -14.3% and EPS is at +210.2%, with operating margin around 4.4%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 3.3%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -10.1% over the next 5 trading days and finished higher after 0 of those reports.
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 14, 2026 | โ | -2.5% | -5.9% | -12.9% |
2026 Feb 12, 2026 | -3.3% | -18.1% | -14.7% | -29.8% |
2025 Nov 6, 2025 | +13.3% | -15.8% | -9.7% | -7.8% |
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
NUS
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
NUS Max Drawdown
-59.89%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for NUS and SPY.

Company Overview
Nu Skin Enterprises, Inc.
New York Stock Exchange
Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.